Rakhee Vatsa, Damanpreet Kaur, Shashank Singh Shekhar, Anupriya Chhabra, Sudipta Chakraborty, Ashutosh Dash, Jaya Shukla, Bhagwant Rai Mittal
OBJECTIVE: Bone is considered as the third most common site of metastases, besides lung and liver. Early detection of skeletal metastases aids in better management of skeletal-related events. In the present study cold kit-based 2,2',2''-(10-(2-((diphosphonomethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid (BPAMD) was labeled with 68Ga. The radiolabeling parameters and clinical evaluation in patients with suspected bone metastases were compared with routinely used 99mTc-methylenediphosphonate (99mTc-MDP)...
March 10, 2023: Nuclear Medicine Communications